SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $108M invested in SPDR S&P Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 10 closing their positions.
Holders
72
Holders Change
+7
Holders Change %
+10.77%
% of All Funds
1.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
15
Reduced
19
Closed
10
Calls
$901K
Puts
$1.04M
Net Calls
-$139K
Net Calls Change
+$791K
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| – | – | -7,134 | Closed |
|
|
EW
77
Evoke Wealth
Los Angeles,
California
| – | – | -3,200 | Closed |
|
78
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | – | -1,845 | Closed |
|
|
HI
79
Harbour Investments
Madison,
Wisconsin
| – | – | -485 | Closed |
|
|
SWA
80
Sutton Wealth Advisors
Tampa,
Florida
| – | – | -138 | Closed |
|
|
FRA
81
Front Row Advisors
Tiburon,
California
| – | – | -45 | Closed |
|
|
PTC
82
Private Trust Company
Cleveland,
Ohio
| – | – | -31 | Closed |
|
83
Simplex Trading
Chicago,
Illinois
| $0 | 10 | +10 | New |
|